Comparative pharmacokinetics and bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate-to-severe facial erythema associated with rosacea-Reference-Cited by-同舟云学术

Comparative pharmacokinetics and bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate-to-severe facial erythema associated with rosacea

Published:2014-07 Issue:1 Volume:171 Page:162-169
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Benkali K.¹,Leoni M.²,Rony F.¹,Bouer R.¹,Fernando A.²,Graeber M.²,Wagner N.¹

Affiliation:

1. Galderma R&D; Sophia Antipolis France

2. Galderma R&D; Princeton NJ U.S.A

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.12881/fullpdf

Reference12 articles.

1. Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose response, and dosing studies;Walters;Surv Ophthalmol,1996

2. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment;Greenfield;J Glaucoma,1997

3. Once-daily topical brimonidine tartrate gel 0.5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies;Fowler;Br J Dermatol,2012

4. Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies;Fowler;J Drugs Dermatol,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. About the pathways to deliver brimonidine to the Muller’s muscle;JAAD Case Reports;2023-03

2. Efficacy and safety of topical brimonidine in dermatology: A review article;Dermatologic Therapy;2022-10-03

3. Eyelid ptosis following botulinum toxin injection treated with brimonidine 0.33% topical gel;JAAD Case Reports;2022-04

4. HPLC–MS/MS studies of brimonidine in rabbit aqueous humor by microdialysis;Bioanalysis;2021-10

5. Difference in Vasoconstrictors: Oxymetazoline Versus Brimonidine;Rosacea;2020